Cardiocast

Biodegradable stent polymer offers no long-term protection


 

This week from MDedge Cardiology, a biodegradable polymer shows no long-term benefit in heart stents, appropriate use criteria for imaging in nonvalvular heart disease are released, ACOG updates guidance on hypertension in pregnancy, and more losartan lots are recalled.

Subscribe to Cardiocast wherever you get your podcasts.

Amazon AlexaApple Podcasts

Recommended Reading

Get on top of home BP monitoring now
MDedge Endocrinology
SPRINT: Pill burden affects ability to reach systolic BP control
MDedge Endocrinology
Psoriasis adds to increased risk of cardiovascular procedures, surgery in patients with hypertension
MDedge Endocrinology
Young adults with hypertension may be at higher CVD risk
MDedge Endocrinology
High incidence of treatment-resistant hypertension in SLE comes with high mortality
MDedge Endocrinology
Barbershop BP intervention going strong at 12 months
MDedge Endocrinology
Opioids don’t top NSAIDs for chronic pain
MDedge Endocrinology
Firibastat looking good for difficult-to-treat hypertension
MDedge Endocrinology
Cerebral small vessel disease progression linked to MCI in hypertensive patients
MDedge Endocrinology
Torrent Pharmaceuticals expands losartan recall
MDedge Endocrinology